NewGenIvf Group Ltd (NIVF): Cash & Equivalents
$758.6K
As of 2025-12-31
+202.0%
3-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $758.6K | +65.7% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $457.7K | +746.0% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $54.1K | +96.3% | 2025-05-15, Balance as of period end |
| 2022-12-31 | $27.6K | n/a | 2024-08-20, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| NewGenIvf Group Ltd (NIVF) | 2025-12-31 | $758.6K | +65.7% |
| Cryo Cell International Inc (CCEL) | 2025-11-30 | $319.0K | -43.1% |
| Mangoceuticals, Inc. (MGRX) | 2025-12-31 | $1.49M | n/m |
| Pacific Health Care Organization Inc (PFHO) | 2025-12-31 | $2.17M | +4.7% |
| Marpai, Inc. (MRAI) | 2025-12-31 | $133.0K | -82.6% |
| Charming Medical Ltd (MCTA) | 2026-03-31 | $4.70M | +475.3% |
| Viemed Healthcare, Inc. (VMD) | 2025-12-31 | $13.50M | -23.0% |
| BioRestorative Therapies, Inc. (BRTX) | 2025-12-31 | $1.51M | +175.8% |
| Progyny, Inc. (PGNY) | 2025-12-31 | $112.24M | -30.9% |
Compare NIVF, CCEL, MGRX, PFHO side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗